car-t vs. bites in b-cell malignancies
Published 3 years ago • 415 plays • Length 6:02Download video MP4
Download video MP3
Similar videos
-
1:59
car t-cells and bites for hematological malignancies
-
6:09
car-t vs. bites in b-cell malignancies
-
3:06
car-t and bites – which targets belong in clinical practice?
-
3:17
challenges and next steps for car-t in b-cell lymphomas
-
3:10
immunology wars: monoclonal antibodies
-
4:16
car t-cell therapy
-
9:11
chimeric antigen receptor car technique - creative biolabs (original version)
-
2:17
the role of car t-cell therapy for treating myeloma in the era of bispecific antibodies
-
1:38
the future of car-t for hematological malignancies and solid tumors
-
2:30
car t-cells vs. car nk-cells
-
1:27
car t-cells in all: an overview
-
1:39
the role of myeloid cells in car-t cell therapy
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
1:02
the use of car-t cell products in a real-world setting
-
2:05
the cost-effectiveness of car t-cell therapy
-
1:28
assessment of car-t and tcr adverse events
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:17
tcxpress™ vs car-t therapy & targeting leukemia with tcr t-cells
-
1:31
price vs. performance: car t-cells
-
1:34
keynote lectures and bite vs car-t debate
-
1:26
ebmt guidelines car-t education & guidelines for nurses